how many people are using glp 1 Opportunities for nutrition brands in the GLP-1 boom Rising use of GLP-1 medications

In a 40-week double blinded, placebo-controlled study, weekly injections of Tirzepatide (15mg) in Type 2 Diabetes Mellitus (T2DM) patients was capable of reducing body weight by an average of 10.1%, over placebo at 40 weeks

Archived from the original on 12 April 2025

She explains why the microbiome changes during perimenopause, why so many women experience weight-loss resistance, the role of stress and immunity, and how hormone replacement therapy, strength training, protein, and fiber can help women age with resilience.In this episode:Cynthia's near-death health crisisThe gut-hormone connectionImmune system agingWeight loss resistance explainedThe microbiome and GLP-1The gut-bone axisWhy stress changes everythingPractical strategies for women in midlifeWhat if menopause isn't just about hormones?In this conversation, nurse practitioner and author Cynthia Thurlow explains why your gut microbiome may be one of the biggest missing pieces in women's health

The xylan bioconversion from agricultural residues into XOS without prior pre-treatment has been revealed to be possibly economical alternate for industrial application

Can I lose more weight with Contrave or Wegovy

For a lot of us, that can lead to chronic inflammation, chronic pain and developing lots of allergies. After adjusting to the medication, she: Lowered her basal insulin by 20%